Free Trial

TruBridge (TBRG) Projected to Post Earnings on Thursday

TruBridge logo with Medical background

Key Points

  • TruBridge (NASDAQ:TBRG) is set to report its Q2 2025 earnings on Thursday, August 7th, with expectations for earnings of $0.29 per share and revenue of $86.68 million.
  • The company previously reported Q1 results on May 9th, missing earnings estimates with $0.29 per share but exceeding revenue expectations at $87.21 million.
  • TruBridge shares have seen a 1.3% decline recently, closing at $20.54, with institutional investors holding 88.64% of the stock.
  • MarketBeat previews top five stocks to own in September.

TruBridge (NASDAQ:TBRG - Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Thursday, August 7th. Analysts expect TruBridge to post earnings of $0.29 per share and revenue of $86.68 million for the quarter.

TruBridge (NASDAQ:TBRG - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The company reported $0.29 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by ($0.08). TruBridge had a negative net margin of 5.86% and a positive return on equity of 0.33%. The company had revenue of $87.21 million for the quarter, compared to the consensus estimate of $86.21 million. On average, analysts expect TruBridge to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

TruBridge Stock Down 1.3%

TBRG stock traded down $0.28 on Friday, reaching $20.54. 114,535 shares of the company traded hands, compared to its average volume of 171,362. TruBridge has a one year low of $9.75 and a one year high of $32.00. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.69 and a quick ratio of 1.68. The company has a market cap of $308.51 million, a P/E ratio of -15.21 and a beta of 0.62. The firm has a fifty day simple moving average of $23.03 and a 200-day simple moving average of $25.00.

Analyst Ratings Changes

Separately, Stephens reaffirmed an "equal weight" rating and set a $28.00 price objective on shares of TruBridge in a research report on Thursday, April 10th.

Read Our Latest Stock Report on TruBridge

Insider Buying and Selling

In other TruBridge news, CEO Christopher L. Fowler sold 6,000 shares of the stock in a transaction on Friday, May 16th. The stock was sold at an average price of $25.05, for a total transaction of $150,300.00. Following the sale, the chief executive officer directly owned 131,090 shares in the company, valued at approximately $3,283,804.50. This trade represents a 4.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 10.70% of the company's stock.

Institutional Trading of TruBridge

Several institutional investors have recently added to or reduced their stakes in the business. Dynamic Technology Lab Private Ltd purchased a new stake in TruBridge during the 1st quarter valued at $221,000. Goldman Sachs Group Inc. boosted its stake in shares of TruBridge by 31.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 152,668 shares of the company's stock worth $4,201,000 after buying an additional 36,838 shares during the last quarter. Finally, Millennium Management LLC boosted its stake in shares of TruBridge by 20.9% in the 1st quarter. Millennium Management LLC now owns 226,172 shares of the company's stock worth $6,224,000 after buying an additional 39,090 shares during the last quarter. 88.64% of the stock is currently owned by hedge funds and other institutional investors.

TruBridge Company Profile

(Get Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Featured Stories

Earnings History for TruBridge (NASDAQ:TBRG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in TruBridge Right Now?

Before you consider TruBridge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.

While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines